Enhancer ID: | E_01_0966 |
Species: | human |
Position : | chr13:27917232-27919232 |
Biosample name: | |
Experiment class : | High+Lowthroughput |
Enhancer type: | Enhancer |
Disease: | Insulinoma |
Pubmed ID: | 33060578 |
Enhancer experiment: | PCR |
Enhancer experiment description: | NFaT transcription factors, rather than the cano_x005f_x0002_nical PDX1 enhancer complex, are predicted to drive INS transactivation. |
Target gene : | -- |
Strong evidence: | qRT-PCR,qPCR,ChIP,3C |
Less strong evidence: | RNA-Seq |
Target gene experiment description: | NFaT transcription factors, rather than the cano_x005f_x0002_nical PDX1 enhancer complex, are predicted to drive INS transactivation. |
TF name : | PDX1(GSF,IDX-1,IPF1,IUF1,MODY4,PAGEN1,PDX-1,STF-1) |
TF experiment: | PCR |
TF experiment description: | NFaT transcription factors, rather than the cano_x005f_x0002_nical PDX1 enhancer complex, are predicted to drive INS transactivation. |
Enhancer function : | NFaT transcription factors, rather than the cano_x005f_x0002_nical PDX1 enhancer complex, are predicted to drive INS transactivation. |
Enhancer function experiment: | Immunohistochemical staining |
Enhancer function experiment description: |
NFaT transcription factors, rather than the cano_x005f_x0002_nical PDX1 enhancer complex, are predicted to drive INS transactivation. |
SNP ID: | -- |
GeneName | Pathway Name | Source | Gene Number |
---|---|---|---|
PDX1 | FOXA2 and FOXA3 transcription factor networks | pid | 45 |
PDX1 | Regulation of gene expression in beta cells | reactome | 17 |
PDX1 | Regulation of gene expression in early pancreatic precursor cells | reactome | 8 |
PDX1 | Type II diabetes mellitus | kegg | 44 |
PDX1 | Maturity onset diabetes of the young | kegg | 25 |